Short-term administration of leptin into the cerebral ventricles increases renal sympathetic activity, while long-term intravenous leptin infusions in nonobese rodents at rates similar to the levels found in severe obesity increase arterial pressure and heart rate through adrenergic activation [110]. Here, LEP is linked to obesity disorder.